Where does Clarify Health Solutions, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Clarify Health Solutions, Inc. ranks #13,360 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Clarify Health Solutions, Inc. hold?

Clarify Health Solutions, Inc. holds 22 US utility patents granted between 2020 and 2025, spanning 5 technology areas.

What is Clarify Health Solutions, Inc.'s Innovation Score?

Clarify Health Solutions, Inc. has an Innovation Score of 33.3 out of 100 (44th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Clarify Health Solutions, Inc. focus on?

Clarify Health Solutions, Inc.'s top technology area is G06N (Computing Arrangements Based ON Specific Computational Models) with 20 patents, ranking #458 of 4,479 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Clarify Health Solutions, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Clarify Health Solutions, Inc..

What does claim depth mean for Clarify Health Solutions, Inc.'s patents?

Clarify Health Solutions, Inc.'s patents average 12.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Clarify Health Solutions, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Clarify Health Solutions, Inc.

USPTO PatentsView assignee record - 22 granted patents across 5 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06N (Computing Arrangements Based ON Specific Computational Models).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Clarify ranks #13,360 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 5 technology areas.

#13,360
of 49,997 US assignees by volume: 44th percentile
by Innovation Score (33.3/100): 12.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R13360 · US Corporation #13,360 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 22 grants
MID-PACK #13,360/49,997
PHOTO-FINISH Celsee Diagnostics
CPC-NARROW G06N · 5 areas
INNOV-THIN 33.3/100
CLAIMS-RICH 12.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Celsee Diagnostics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clarify’s 33.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (33%) Velocity 7.3 pts (22%) Breadth 7.9 pts (24%) Claim depth 7.2 pts (22%)

Qualcomm Incorporated · highest

85
Clarify Health… · this assignee

33
3D Lighting… · lowest

7

What this shows Clarify's Innovation Score is 33.3/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Clarify?

Each dot is one of Clarify’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clarify’s own 12.0 claims/patent is at or below the 13.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Clarify vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clarify's grants concentrate

Clarify Health Solutions, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 90.9% of grants classified under G06N (Computing Arrangements Based ON Specific Computational Models). Peak complete grant year is 2023 (7 grants) versus a trough of 1 in 2024. By volume, Clarify sits between Celsee Diagnostics, Inc. and Control4 Corporation.

Clarify's three-year grant acceleration

Clarify Health Solutions, Inc. shows 11 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Celsee Diagnostics

22
Cerevasc

22
Chongqing Ruzer P…

22
Clariant Plastics…

22
Cleveron AS

22
Coco Communicatio…

22
Communication Com…

22
Control4

22
Clarify Health So… ◀

22

What this shows Clarify holds 22 patents at rank #13,367, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Clarify

By rank, the assignees closest to #13,367 in granted patent volume.

Leaders in G06N (Computing Arrangements Based ON Specific Computational Mo…)

Other assignees with the most granted patents in Clarify's primary technology class.

Clarify's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Clarify Health Solutions, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	5	22.7%
2021	5	22.7%
2022	3	13.6%
2023	7	31.8%
2024	1	4.5%
2025partial year	1	4.5%

Which technologies does Clarify Health Solutions, Inc. patent most?

G06N - Computing Arrangements Based ON Specific Computational Models 20

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 18

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 10

G06F - Electric Digital Data Processing 6

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 6

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Clarify Health Solutions, Inc.'s patent record in context - here's where to go next.

Clarify Health Solutions, Inc.'s lead technology class is G06N (Computing Arrangements Based ON Specific Computational Models), 90.9% of its portfolio - see every assignee active in that class. Explore G06N
Ranked #13,360 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Clarify Health Solutions, Inc. against Celsee Diagnostics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.